| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/13/2011 | CN102015626A 4-trimethylammonio-butyrates as CPT2 inhibitors |
| 04/13/2011 | CN102015026A Novel nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 04/13/2011 | CN102014915A Adenosine derivatives as partial and full agonists of A1 adenosine receptors |
| 04/13/2011 | CN102014657A Soybean protein material for patients with renal disease and foods made from the same |
| 04/13/2011 | CN102010512A Preparation method and application of water-soluble chitosan micro-particles |
| 04/13/2011 | CN102010473A Recombinant oxyntomodulin (OXM) fusion protein, and preparation and application thereof |
| 04/13/2011 | CN102010460A Tea seed polypeptide and preparation method thereof |
| 04/13/2011 | CN102010453A Flavonol glycosides compound extracted from loropetalum chinense leaf and medicinal application thereof |
| 04/13/2011 | CN102010425A 1,4-disulfide-7-azaspiro [4,4] nonane-8-carboxylic acid derivative histone deacetylase inhibitor and application thereof |
| 04/13/2011 | CN102010387A Method for purifying orlistat |
| 04/13/2011 | CN102010375A Rosuvastatin calcium compound with stable crystal form |
| 04/13/2011 | CN102010298A Indene derivatives as pharmaceutical agents |
| 04/13/2011 | CN102008654A Method for manufacturing dendrobium officinale fresh juice stock solution |
| 04/13/2011 | CN102008634A Chinese medicinal health-care tea for preventing and treating diabetes |
| 04/13/2011 | CN102008632A Glucose-reducing tea for treating diabetes |
| 04/13/2011 | CN102008631A Composition of safflower oil and garlic extract and application thereof |
| 04/13/2011 | CN102008627A Traditional Chinese medicinal preparation for treating diabetic retinopathy |
| 04/13/2011 | CN102008604A Traditional Chinese medical health tea for lowering lipid and protecting liver and preparation method thereof |
| 04/13/2011 | CN102008600A Steam bath health-preserving fumigation powder |
| 04/13/2011 | CN102008598A Blood fat-lowering and liver-protecting composite as well as preparation prepared thereby and preparation method of preparation |
| 04/13/2011 | CN102008578A Production process of trifoliate orange Cherokee rose capsules |
| 04/13/2011 | CN102008538A Combined application of rhodiola sacra preparation and medicine resisting mental disease and tristimania for efficacy enhancement and toxicity reduction |
| 04/13/2011 | CN102008528A Compound sea cucumber preparation and preparation method thereof |
| 04/13/2011 | CN102008518A Seabuckthorn seed oil liposome preparation process |
| 04/13/2011 | CN102008515A Construction method of ganoderma spore powder polysaccharide fingerprint and standard fingerprint of ganoderma spore powder polysaccharide |
| 04/13/2011 | CN102008514A Traditional Chinese medicinal preparation and preparation method and applications thereof |
| 04/13/2011 | CN102008505A Bear gall preparation resistant to injuries of organ, such as muscle, and the like caused by statins |
| 04/13/2011 | CN102008489A Liquid multi-dimensional formula, and preparation process and application thereof |
| 04/13/2011 | CN102008477A Method for preparing tablet drug composition containing Rosuvastatin calcium |
| 04/13/2011 | CN102008474A Application of nitidine chloride to preparation of medicament for resisting autoimmunity disease and graft versus host disease |
| 04/13/2011 | CN102008472A Compound pioglitazone hydrochloride/metformin hydrochloride bilayer osmotic pump controlled release preparation and preparation method thereof |
| 04/13/2011 | CN102008468A Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases |
| 04/13/2011 | CN102008454A Daidzein-entrapped PLGA nanoparticles and preparation method thereof |
| 04/13/2011 | CN102008440A Solid preparation of atorvastatin calcium liposome |
| 04/13/2011 | CN102008406A Synthesis essential oil for body slimming and body building |
| 04/13/2011 | CN102008078A Method for preparing 1,3-diglyceride-containing milk fat in solvent-free system with all-enzymatic method |
| 04/13/2011 | CN102007988A Traditional Chinese medicinal weight-losing and health-care tea |
| 04/13/2011 | CN101757599B Medicinal granules comprising brown sugar, Colla corii Asini, Cornu cervi Pantotrichum, ginseng, clove, costus root, red jujube and tea |
| 04/13/2011 | CN101744970B Medicine used for type 2 diabetes and preparation method thereof |
| 04/13/2011 | CN101601640B Cocoon sericin layer alcohol soluble substance and preparation method thereof |
| 04/13/2011 | CN101550125B Hazelnut element B, extracting method and pharmaceutical use thereof |
| 04/13/2011 | CN101524331B Polysaccharide-liposome and preparation method and purpose thereof |
| 04/13/2011 | CN101519457B Method for preparing beta-ethoxy rutinose and application thereof for reducing blood glucose |
| 04/13/2011 | CN101485646B Andrographolide catablasm and preparation method thereof |
| 04/13/2011 | CN101461804B (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 04/13/2011 | CN101444496B Compounds for the treatment of metabolic disorders |
| 04/13/2011 | CN101346352B 不对称还原方法 Asymmetric reduction method |
| 04/13/2011 | CN101307090B Method for preparing timosaponin BIII and uses thereof |
| 04/13/2011 | CN101267823B Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 04/13/2011 | CN101244134B New purpose of naodesheng extract for treating diabetes complication |
| 04/13/2011 | CN101238909B Chickpea bean sprout juice and preparation method and application |
| 04/13/2011 | CN101233942B Method for cooking medicinal diet kidney-tonifying yang-invigorating soup |
| 04/13/2011 | CN101190238B Method for using shrimp shell mud fermentation to produce biological calcium product |
| 04/13/2011 | CN101171011B Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating apetite disorder |
| 04/13/2011 | CN101167875B Traditional Chinese medicinal preparation for treating diabetes and its preparing process |
| 04/13/2011 | CN101115709B Aminocarboxylic acid derivative and medicinal use thereof |
| 04/13/2011 | CN101053641B Baoyuan kidney-invigorating navel plaster |
| 04/12/2011 | US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/12/2011 | US7923008 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab |
| 04/12/2011 | US7922999 Administration of growth factors for the treatment of CNS disorders |
| 04/12/2011 | CA2592367C Novel cyclohexane derivatives |
| 04/12/2011 | CA2526771C Synthesis of high molecular weight iron-saccharidic complexes |
| 04/12/2011 | CA2474875C 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2,-a]pyrimidin-5(1h)-one derivatives |
| 04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |
| 04/08/2011 | CA2717157A1 Nutritional drink |
| 04/07/2011 | WO2011041710A2 Docosahexaenoic acid gel caps |
| 04/07/2011 | WO2011041632A2 Combination therapies for the treatment of obesity |
| 04/07/2011 | WO2011041385A2 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis |
| 04/07/2011 | WO2011041154A1 Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts |
| 04/07/2011 | WO2011040823A1 Synthetic myostatin peptide antagonists |
| 04/07/2011 | WO2011040654A1 Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same |
| 04/07/2011 | WO2011040597A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same |
| 04/07/2011 | WO2011040449A1 Novel phenol derivative |
| 04/07/2011 | WO2011040342A1 Agent for inhibiting decrease of visceral fat in patient with parkinson's disease |
| 04/07/2011 | WO2011040004A1 Novel phenylpyridine derivative and medicinal agent comprising same |
| 04/07/2011 | WO2011039999A1 Composition having lipolysis-promoting effect |
| 04/07/2011 | WO2011039729A1 Use of sirna targetting sipa1l1 for the reduction of adipogenesis |
| 04/07/2011 | WO2011039367A2 Therapeutic uses of pharmaceutical compositions |
| 04/07/2011 | WO2011039358A1 Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 04/07/2011 | WO2011039176A1 Bifidobacterium longum atcc baa-999 (bl999) and weight control |
| 04/07/2011 | WO2011039096A1 Drug fusions and conjugates with extended half life |
| 04/07/2011 | WO2011038700A1 Inhibitors of fam3b gene, inhibitor compositions, inhibiting methods and applications of inhibitors in preparing pharmaceuticals |
| 04/07/2011 | WO2011019641A3 Nutritional compositions including exogenous nucleotides |
| 04/07/2011 | WO2010135505A3 Crystalline forms of 4-[6-(6-methanesulfonyl-2-methylpyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester |
| 04/07/2011 | WO2010091104A8 Glucosylceramide synthase inhibitors |
| 04/07/2011 | US20110083201 Compositions for and methods of grazyme b inhibition |
| 04/07/2011 | US20110082407 Combination Therapies for the Treatment of Obesity |
| 04/07/2011 | US20110082210 Fatty acid fibrate derivatives and their uses |
| 04/07/2011 | US20110082206 Heteroatom containing substituted fatty acids |
| 04/07/2011 | US20110082205 Docosahexaenoic Acid Gel Caps |
| 04/07/2011 | US20110082202 Fatty acid acifran derivatives and their uses |
| 04/07/2011 | US20110082195 New use for cannabinoids |
| 04/07/2011 | US20110082192 Lipoic acid acylated salicylate derivatives and their uses |
| 04/07/2011 | US20110082183 Phenyl pyrrole aminoguanidine derivatives |
| 04/07/2011 | US20110082178 Methods of treating autoimmune and inflammatory diseases and disorders |
| 04/07/2011 | US20110082176 Stilbenes and Chalcones for the Prevention and Treatment of Cardiovascular Diseases |
| 04/07/2011 | US20110082172 Pyrrolidinone carboxamide derivatives |
| 04/07/2011 | US20110082166 Novel 4-benzhydryl-tetrahydro-pyridine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/07/2011 | US20110082165 Pyrrolidine gpr40 modulators |
| 04/07/2011 | US20110082164 Polycyclic compounds as lysophosphatidic acid receptor antagonists |